A cardiac myxoma, commonly identified through ultrasound (US) findings, is the most prevalent type of primary heart tumor. These non-cancerous growths typically originate in the left atrium, appearing as a heterogeneous, often mobile mass with variable echogenicity on echocardiography. Early detection via cardiac ultrasound is crucial for diagnosis and to prevent complications such as embolic events or obstruction of blood flow.
Medical ultrasound plays a vital role in characterizing myxomas, assessing their size, attachment, and impact on cardiac function. Sonographers and cardiologists utilize this imaging modality to guide treatment decisions, which often involve surgical removal. Understanding myxoma US findings is essential for accurate diagnosis and patient management in cardiovascular care.